PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1794530
PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1794530
Global Obesity Surgery Devices Market to Reach US$2.5 Billion by 2030
The global market for Obesity Surgery Devices estimated at US$1.8 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Gastric Balloons, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$1.6 Billion by the end of the analysis period. Growth in the Gastric Bands segment is estimated at 3.6% CAGR over the analysis period.
The U.S. Market is Estimated at US$490.7 Million While China is Forecast to Grow at 8.8% CAGR
The Obesity Surgery Devices market in the U.S. is estimated at US$490.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$502.8 Million by the year 2030 trailing a CAGR of 8.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.6% and 5.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.
Global Obesity Surgery Devices Market - Key Trends & Drivers Summarized
How Are Shifting Clinical Strategies Influencing Demand for Obesity Surgery Devices?
Obesity surgery devices are gaining importance as clinical strategies shift from conservative weight management approaches to more interventional treatments for severe obesity. Rising global prevalence of obesity-related comorbidities such as type 2 diabetes, cardiovascular disease, and sleep apnea has prompted clinicians to adopt bariatric surgery more widely as a medically necessary intervention. As a result, surgical interventions such as gastric bypass, sleeve gastrectomy, and adjustable gastric banding are being used beyond cosmetic reasons to address metabolic disorders. This shift is driving consistent demand for a broad range of devices including stapling systems, gastric bands, suturing devices, and balloon systems.
Surgeons and hospitals are increasingly integrating minimally invasive devices that reduce operation time and postoperative recovery. This is expanding the role of advanced laparoscopic instruments and robotic-assisted tools in bariatric procedures. Adjustable gastric bands and endoscopic sleeves are being used selectively in patients who may not qualify for more invasive surgeries but require clinical weight loss support. Such flexibility in device selection is contributing to higher adoption rates. Additionally, guidelines and insurance coverage are evolving in several regions, further normalizing surgical treatment for obesity and increasing the volume of device-assisted interventions in public and private healthcare settings.
What Technological Shifts Are Redefining Device Innovation in This Segment?
Obesity surgery devices are undergoing notable evolution in terms of both material design and functionality. Manufacturers are focusing on creating devices that offer higher precision, ease of deployment, and reduced complications. For example, the development of biodegradable gastric balloons and enhanced suturing systems is helping address limitations related to device removal and long-term complications. Disposable laparoscopic tools and automated stapling systems are also becoming more common, especially in high-throughput surgical centers where infection control and procedural efficiency are critical.
Robotic platforms are beginning to influence surgical workflows in obesity treatment. Devices integrated with robotic arms are being designed for enhanced dexterity and precision, especially in revisional bariatric procedures. Meanwhile, innovation in endoluminal devices is supporting the growing segment of incisionless or low-risk procedures. These devices, which work entirely within the gastrointestinal tract, are being tested and adopted for weight loss in patients who cannot undergo conventional surgery. Such advancements not only improve patient outcomes but also expand the overall addressable patient base for obesity surgery devices. This is encouraging more hospitals to invest in technologically upgraded instruments and workflows.
Where Are Hospitals and Surgeons Focusing Device Use in Real-World Settings?
Hospitals and surgical centers are aligning their device preferences with population-level needs and surgical specialization. In high-obesity regions, demand for vertical sleeve gastrectomy devices remains prominent due to the balance it offers between effectiveness and procedural safety. This has led to high-volume usage of surgical staplers and energy-based dissection tools. Adjustable gastric band systems, although witnessing reduced uptake in many Western markets, are still in use in specific populations and private practices, especially where patients opt for reversible procedures. Surgeons in Asia-Pacific and Latin America continue to perform a mix of laparoscopic and open bariatric surgeries depending on infrastructure and patient profile, driving varied demand for conventional and advanced instruments.
Endoscopic and balloon-based devices are being favored in outpatient settings and ambulatory surgical centers, especially in urban areas with growing interest in non-invasive weight loss solutions. These centers are investing in intragastric balloon systems and transoral endoscopic devices that enable same-day discharge and shorter follow-up cycles. In teaching hospitals and bariatric specialty centers, robotic tools and high-definition visualization systems are being adopted to handle more complex or repeat surgeries, often involving patients with prior failed interventions. This stratification in care delivery settings is shaping the procurement and application patterns for obesity surgery devices across global markets.
Growth in the Obesity Surgery Devices market is driven by several factors…
Growth in the obesity surgery devices market is driven by several factors directly linked to procedural trends, technological innovation, and healthcare practice evolution. Increasing global adoption of sleeve gastrectomy and gastric bypass as standard treatments for obesity is expanding demand for precision stapling and cutting tools. Uptake of robotic-assisted surgery for bariatric procedures is also contributing to device sales, especially those compatible with robotic platforms. Technological improvements in intragastric balloons and endoluminal suturing devices are enabling minimally invasive procedures, making such devices attractive in both private and ambulatory care settings.
Rising use of disposable laparoscopic tools in infection-sensitive environments is influencing purchasing behavior in high-volume surgical centers. Adoption of devices with better ergonomics, material compatibility, and lower risk of leakage or migration is becoming a procurement priority in hospitals. In emerging markets, increasing investments in laparoscopic surgery infrastructure and surgeon training are supporting broader usage of both conventional and advanced obesity surgery tools. In addition, expansion of insurance coverage and inclusion of obesity surgeries under public health initiatives are creating stable demand for clinically approved and reimbursement-compatible devices.
SCOPE OF STUDY:
The report analyzes the Obesity Surgery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Device (Gastric Balloons, Gastric Bands, Stapling Devices); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Ambulatory Surgery Centers End-Use)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 34 Featured) -
AI INTEGRATIONS
We're transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.